Federal contract award

HT940220F0009

THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5).

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeDEFENSE HEALTH AGENCY
NAICS541611 — Administrative Management and General Management Consulting Services
PSCR707 — Contract, Procurement, and Acquisition Support Services
Parent award / vehicleGS10F0262L
Set-asideNot reported
Pricing typeFIXED PRICE LEVEL OF EFFORT
Obligations$13.0M
Current contract value$13.0M
Potential contract value / ceiling$13.0M
Start dateApr 3, 2020
Current end dateDec 12, 2025
Potential end dateDec 12, 2025
Latest award activityDec 12, 2025
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Dec 12, 2025P00020$0THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5).
Jul 21, 2025P00019$-5.7KTHE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5).
May 22, 2025P00018$114.0KTHE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5).
Feb 14, 2025P00017$228.0KTHE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5).
Dec 26, 2024P00016$-490.4KTHE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5).

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.